Genomics

Dataset Information

33

Two types of estrogen receptor-positive (ER+) and -negative (ER-) breast cancer will be compared with glycan structure analyses


ABSTRACT: ER+ve and ER-ve breast cancers tend to show different patterns of metastasis, with ER+ve tumours having a propensity to metastasize to the bone while ER-ve tumours tend to induce visceral metastasis. Glycans can play an important role in metastasis through their interactions with glycan binding proteins. Moreover we, and others have also shown that expression of particular tumor-associated glycoforms of the mucin MUC1, allows it to interact with lectins of the immune system. We now have data showing differences in the level of expression of some glycosyltransferases in ER+ve and ER-ve of breast cancer suggesting the expression of different O-linked glycoforms. Overall design: RNA will be isolated from ER+ve and ER-ve primary breast cancers supplied by the Guy’s and St Thomas’ Research Breast Tissue Bank. Tumor tissue will be macro-dissected from thick cryostat sections by visual comparison with a representative H&E section. We will verify the level of expression of ER and document the expression of ST3Gal-I and ST6GalNAc-II by RT-qPCR. We have already isolated RNA from a number of tumours and shown we can obtain RNA of good quality with a RNA integrity number, as measured with an Agilent Bioanalyser, of >4.5 Since there is likely to be variability among primary tumors, ideally we analyzed of 10 ER negative and 9 ER positive tumours.

INSTRUMENT(S): [Glyco_v4_Hs] Custom Affymetrix Glyco v4 GeneChip

ORGANISM(S): Homo sapiens  

SUBMITTER: Steven Head  

PROVIDER: GSE32394 | GEO | 2011-09-26

SECONDARY ACCESSION(S): PRJNA147945

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
GSE32394_RAW.tar Raw
filelist.txt Txt
Items per page:
1 - 2 of 2

Similar Datasets

2011-09-25 | E-GEOD-32394 | ArrayExpress
1000-01-01 | S-EPMC3446380 | BioStudies
2017-01-01 | S-EPMC5487720 | BioStudies
2017-01-01 | S-EPMC5352113 | BioStudies
2019-01-01 | S-EPMC6323053 | BioStudies
1000-01-01 | S-EPMC5075711 | BioStudies
2019-01-01 | S-EPMC6889395 | BioStudies
2011-01-01 | S-EPMC3084334 | BioStudies
2004-01-01 | S-EPMC4392521 | BioStudies
2003-01-01 | S-EPMC2377080 | BioStudies